Reduced Dose Intensity of Daunorubicin During Remission Induction for Low-Risk Patients With Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of the Chinese Children's Cancer Group.
Zhuang Y, Wu K, Zhu X, Cai J, Hu S, Gao J, Jiang H, Zhai X, Tian X, Fang Y, Jin R, Hu Q, Jiang H, Wang N, Sun L, Leung WK, Yang M, Pan K, Wu X, Liang C, Shen S, Yu J, Ju X.
Zhuang Y, et al. Among authors: tian x.
Front Oncol. 2022 Jun 7;12:911567. doi: 10.3389/fonc.2022.911567. eCollection 2022.
Front Oncol. 2022.
PMID: 35747795
Free PMC article.